Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
PreOncology today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology ...
In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results